Hepatocyte Growth Factor and Cardiac Amyloidosis∗
Main Authors: | Frederick L. Ruberg, MD, Omar K. Siddiqi, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | JACC. CardioOncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087320300120 |
Similar Items
-
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis
by: Kathleen W. Zhang, MD, et al.
Published: (2020-03-01) -
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
by: Giuseppe Vergaro, MD, PhD, et al.
Published: (2021-03-01) -
Cardiac Amyloidosis Therapy: A Systematic Review
by: Franco Iodice, et al.
Published: (2021-01-01) -
Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease
by: Marco Giuseppe Migliaccio, et al.
Published: (2021-07-01) -
Cardiac Amyloidosis
by: Rajiv Ananthakrishna, MBBS, DM, et al.
Published: (2020-02-01)